New York City, New York Nov 4, 2019 (Issuewire.com) - Specializing in critical care medicine, Dr. Ochoa is a board-certified trauma surgeon who completed his training in Medellin, Colombia, which was the epicenter of essentially of the “Drug Wars.” During that time, injuries and trauma were an everyday event.
Having had a lifelong passion for the power of nutritional therapy to transform lives, he currently serves as the Chief Medical Officer of Nestlé Health Science North America. After years of studying the active ingredients in IMPACT Advanced Recovery Drink and using it in his surgical patient population, he decided to join Nestlé Health Science to help raise awareness among surgeons about the benefits to surgery and trauma patients.
“Growing up, my mother worked as a biochemist and my father was a pediatric surgeon, so I almost lived at the medical school and hospital. I actually had my first communion in the hospital. I remember doing rounds with my father when I was very, very young. Viewing every minute as a teachable moment, my father told me the story of how nutritional therapy helped his patients recover from surgery. I was fascinated by the whole idea that you could feed somebody a different type of food and that you could save lives by doing that,” stated Dr. Ochoa.
A native of Colombia, he came to the United States to pursue his interests in basic research. He was the first to demonstrate that excessive nitric oxide production in humans could explain the hemodynamic instability of sepsis. After earning his Medical Degree from Pontifical Bolivarian University in Medellín, Colombia in 1982, Dr. Ochoa went on to complete his residency in general surgery and his fellowship in surgical critical care at the University of Pittsburgh Medical Center in Pittsburg, Pennsylvania.
Thereafter, he decided to take the challenge of becoming an Assistant Professor of Surgery at the University of Kentucky, where he continued his independent research on nitric oxide production in trauma and surgery patients. In 2001, he was invited back to the University of Pittsburgh, where he continued his clinical practice as Professor of Surgery and Critical Care and rose through the ranks to become the Associate Director for Trauma Services at the University of Pittsburgh Medical Center. While sustaining an active clinical practice, he continued to maintain the National Institute of Health-funded research in the area of arginine metabolism during critical illness.
In addition to being a Fellow of the American College of Surgeons and a Fellow of the Society of Critical Care Medicine, the doctor is board-certified in both surgery and surgical critical care by the American Board of Surgery (ABS). The ABS is an independent, non-profit organization located in Philadelphia, Pennsylvania, founded for the purpose of certifying surgeons who have met a defined standard of education, training, and knowledge.
In regards to his professional achievements, Dr. Ochoa has published over 100 manuscripts, including chapters and peer-reviewed articles in prestigious journals. In 2008, he was interviewed by Ms. Jean Marx in SCIENCE, the journal, with regards to the discovery of arginine destruction by myeloid cells. His work has been essential at defining arginine deficiency as a cause of immune dysfunction in several illnesses, including surgery, trauma, and certain cancers.
Learn More about Dr. Juan B. Ochoa:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/2654334-Juan-Ochoa-Doctor or through Nestlé Health Science North America, https://www.nestlehealthscience.us/our-stories/nutrition_on_the_surgical_frontlines
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know how to make informed decisions for you and your family.
Media Contact
Your Health Contact *****@yourhealthcontact.com
